INS and type 1 diabetes mellitus: The most important aspect of this research is to analyze how beneficial it is to improve HBA1c at the expense of euglycemic DKA. We have critically analyzed this group of medications as these can be a groundbreaking addition to the typical regimen of insulin-only treatment for type 1 diabetes patients, especially for those with uncontrolled diabetes.